TSHA
Taysha Gene Therapies Inc

2,036
Mkt Cap
$1.5B
Volume
2.26M
52W High
$5.96
52W Low
$1.05
PE Ratio
-16.53
TSHA Fundamentals
Price
$5.86
Prev Close
$5.49
Open
$5.55
50D MA
$4.79
Beta
1.61
Avg. Volume
3.92M
EPS (Annual)
-$0.357
P/B
7.33
Rev/Employee
$114,150.68
Loading...
Loading...
News
all
press releases
Taysha Gene Therapies (NASDAQ:TSHA) Reaches New 1-Year High - Here's What Happened
Taysha Gene Therapies (NASDAQ:TSHA) Sets New 52-Week High - Here's Why...
MarketBeat·11h ago
News Placeholder
More News
News Placeholder
Taysha Gene Therapies (NASDAQ:TSHA) Rating Increased to Hold at Wall Street Zen
Wall Street Zen upgraded Taysha Gene Therapies from a "sell" rating to a "hold" rating in a research report on Saturday...
MarketBeat·10d ago
News Placeholder
1,203,941 Shares in Taysha Gene Therapies, Inc. $TSHA Purchased by Stempoint Capital LP
Stempoint Capital LP purchased a new stake in Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The...
MarketBeat·13d ago
News Placeholder
B Group Inc. Buys 545,000 Shares of Taysha Gene Therapies, Inc. $TSHA
B Group Inc. lifted its stake in Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Free Report) by 43.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange...
MarketBeat·14d ago
News Placeholder
Taysha Gene Therapies (NASDAQ:TSHA) Hits New 1-Year High - Here's What Happened
Taysha Gene Therapies (NASDAQ:TSHA) Reaches New 12-Month High - Still a Buy...
MarketBeat·14d ago
News Placeholder
Taysha Gene Therapies (NASDAQ:TSHA) Shares Gap Up - Here's Why
Taysha Gene Therapies (NASDAQ:TSHA) Shares Gap Up - Here's What Happened...
MarketBeat·18d ago
News Placeholder
Taysha Gene Therapies (NASDAQ:TSHA) Trading Up 7% - Still a Buy?
Taysha Gene Therapies (NASDAQ:TSHA) Stock Price Up 7% - Should You Buy...
MarketBeat·19d ago
News Placeholder
TSHA FY2026 EPS Forecast Raised by Cantor Fitzgerald
Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Free Report) - Investment analysts at Cantor Fitzgerald lifted their FY2026 EPS estimates for shares of Taysha Gene Therapies in a note issued to investors...
MarketBeat·26d ago
News Placeholder
SG Americas Securities LLC Makes New $1.14 Million Investment in Taysha Gene Therapies, Inc. $TSHA
SG Americas Securities LLC purchased a new stake in shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Free Report) during the second quarter, according to its most recent filing with the...
MarketBeat·30d ago
News Placeholder
Taysha Gene Therapies (NASDAQ:TSHA) Shares Up 2.9% - Here's Why
Taysha Gene Therapies (NASDAQ:TSHA) Shares Up 2.9% - Should You Buy...
MarketBeat·1mo ago
<
1
2
...
>

Latest TSHA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.